Background: Biologic psoriasis treatments are differentiated by efficacy, side effects, and other attributes. Objective: Determine attributes of biologic psoriasis treatments that drive patients’ treatment choices. Methods: Respondents (USA: n = 300; Germany: n = 300) with moderate-to-severe psoriasis completed a discrete-choice–experiment survey, choosing between hypothetical treatments characterized by attributes with varying levels: chance of clear skin after 1 year, number of first-year treatments, first-year risks of mild-to-moderate injection site reaction (ISR) and serious infection, and years of proven efficacy/safety. Results: U.S. respondents most valued clear skin (conditional relative importance, 1.88; p
CITATION STYLE
Feldman, S. R., Poulos, C., Gilloteau, I., Mange, B., Boehm, K., Boeri, M., … Augustin, M. (2022). Exploring determinants of psoriasis patients’ treatment choices: a discrete-choice experiment study in the United States and Germany. Journal of Dermatological Treatment, 33(3), 1511–1520. https://doi.org/10.1080/09546634.2020.1839007
Mendeley helps you to discover research relevant for your work.